Lipocine Inc. Files 2024 Executive Compensation Details

Ticker: LPCN · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1535955

Lipocine Inc. DEF 14A Filing Summary
FieldDetail
CompanyLipocine Inc. (LPCN)
Form TypeDEF 14A
Filed DateApr 22, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: executive-compensation, sec-filing, annual-report

Related Tickers: LPCN

TL;DR

Lipocine Inc. dropped its 2024 exec pay report - check out Mahesh Patel's compensation.

AI Summary

Lipocine Inc. filed its DEF 14A on April 22, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on compensation for key personnel such as Mahesh Patel, a member, and other non-PEO/NEO members, along with adjustments for grant date values. The company's principal business is in pharmaceutical preparations.

Why It Matters

This filing provides transparency into how Lipocine Inc. compensates its top executives, which can influence investor decisions and employee morale.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of executive compensation and does not contain new material financial or operational information.

Key Players & Entities

  • Lipocine Inc. (company) — Filer
  • Mahesh Patel (person) — Executive Compensation Recipient
  • 2024-12-31 (date) — Fiscal Year End
  • 20250422 (date) — Filing Date

FAQ

What is the primary business of Lipocine Inc.?

Lipocine Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].

When was this DEF 14A filing submitted?

The filing was submitted on April 22, 2025.

What fiscal year does this filing primarily cover regarding compensation?

The filing covers the fiscal year ending December 31, 2024.

Who is specifically mentioned in relation to compensation adjustments?

Mahesh Patel and 'ecd:NonPeoNeoMember' are mentioned in relation to compensation adjustments, including 'AdjustmentForGrantDateValuesMember'.

What was Lipocine Inc.'s former company name?

Lipocine Inc.'s former company name was MARATHON BAR CORP, with a date of name change on November 30, 2011.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 by Mahesh Patel regarding Lipocine Inc. (LPCN).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.